<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:content="http://purl.org/rss/1.0/modules/content/"><channel><title>医脉通血液科 | wechat-feeds</title><link>http://MjM5OTA3MzIwMA.favicon.privacyhide.com/favicon.ico</link><description>医脉通血液科主要提供国内外血液前沿资讯，热门血液指南，国内外血液会议报道，精彩血液病例！ “饕餮”血液，尽在医脉通血液科！</description><managingEditor> (hellodword)</managingEditor><pubDate>Thu, 13 May 2021 19:26:06 +0800</pubDate><image><url>http://MjM5OTA3MzIwMA.favicon.privacyhide.com/favicon.ico</url><title>医脉通血液科 | wechat-feeds</title><link>http://MjM5OTA3MzIwMA.favicon.privacyhide.com/favicon.ico</link><width>64</width><height>64</height></image><item><title>他山之石 | 最新获批PK软件经验分享（二）：日本经验</title><link>https://mp.weixin.qq.com/s/dyL9keSAzhzPZX_70pzY3g</link><description></description><content:encoded><![CDATA[他山之石 | 最新获批PK软件经验分享（二）：日本经验]]></content:encoded><pubDate>Thu, 13 May 2021 14:54:21 +0800</pubDate></item><item><title>治疗血液系统恶性肿瘤的靶点及双特异性抗体汇总（一）</title><link>https://mp.weixin.qq.com/s/22mahX3us2tZ4vLc4TMvzQ</link><description></description><content:encoded><![CDATA[治疗血液系统恶性肿瘤的靶点及双特异性抗体汇总（一）]]></content:encoded><pubDate>Thu, 13 May 2021 14:54:21 +0800</pubDate></item><item><title>一例血友病A伴消化道出血患者的诊疗</title><link>https://mp.weixin.qq.com/s/dpjq4rfYQGp70uKNkbuf4Q</link><description></description><content:encoded><![CDATA[一例血友病A伴消化道出血患者的诊疗]]></content:encoded><pubDate>Thu, 13 May 2021 14:54:21 +0800</pubDate></item><item><title>倒计时2天丨淋巴瘤患者全程管理能力提升培训项目通知</title><link>https://mp.weixin.qq.com/s/TC-nd1aQ7l2ZeLRttbeioA</link><description></description><content:encoded><![CDATA[倒计时2天丨淋巴瘤患者全程管理能力提升培训项目通知]]></content:encoded><pubDate>Thu, 13 May 2021 14:54:21 +0800</pubDate></item><item><title>奥妥珠单抗+idelalisib在复发/难治性华氏巨球蛋白血症患者中的应用</title><link>https://mp.weixin.qq.com/s/g5D95bs-is5xpMOAMMYsmQ</link><description></description><content:encoded><![CDATA[奥妥珠单抗+idelalisib在复发/难治性华氏巨球蛋白血症患者中的应用]]></content:encoded><pubDate>Wed, 12 May 2021 18:29:46 +0800</pubDate></item><item><title>Caplacizumab可预防获得性血栓性血小板减少性紫癜的死亡和难治情况：综合分析结果</title><link>https://mp.weixin.qq.com/s/Mp1-KZ3ID9uNjinxPD0CcA</link><description></description><content:encoded><![CDATA[Caplacizumab可预防获得性血栓性血小板减少性紫癜的死亡和难治情况：综合分析结果]]></content:encoded><pubDate>Wed, 12 May 2021 18:29:46 +0800</pubDate></item><item><title>惊喜福利 | 麦粒、csco指南书籍、指南下载券任意选</title><link>https://mp.weixin.qq.com/s/86_fAsmFwcI_wjcgFOyjOg</link><description></description><content:encoded><![CDATA[惊喜福利 | 麦粒、csco指南书籍、指南下载券任意选]]></content:encoded><pubDate>Wed, 12 May 2021 18:29:46 +0800</pubDate></item><item><title>多发性骨髓瘤的NGS方案及临床应用</title><link>https://mp.weixin.qq.com/s/In1j0bWfVtpQ1rz-SvwJjQ</link><description></description><content:encoded><![CDATA[多发性骨髓瘤的NGS方案及临床应用]]></content:encoded><pubDate>Wed, 12 May 2021 18:29:46 +0800</pubDate></item><item><title>一文掌握初诊滤泡性淋巴瘤诊疗</title><link>https://mp.weixin.qq.com/s/6b4KjQx6LgKh1LQZytd8NQ</link><description></description><content:encoded><![CDATA[一文掌握初诊滤泡性淋巴瘤诊疗]]></content:encoded><pubDate>Tue, 11 May 2021 17:09:20 +0800</pubDate></item><item><title>首次探索HLH的T细胞表型：T细胞活化状态可鉴别HLH和早期败血症</title><link>https://mp.weixin.qq.com/s/YH8hSDxy3uif61ERQqoEDQ</link><description></description><content:encoded><![CDATA[首次探索HLH的T细胞表型：T细胞活化状态可鉴别HLH和早期败血症]]></content:encoded><pubDate>Tue, 11 May 2021 17:09:20 +0800</pubDate></item><item><title>4毛钱治好血液病？之前的辅助诊断就不存在了吗？</title><link>https://mp.weixin.qq.com/s/Laj1Prs1nyt-Gne51ue9Jw</link><description></description><content:encoded><![CDATA[4毛钱治好血液病？之前的辅助诊断就不存在了吗？]]></content:encoded><pubDate>Tue, 11 May 2021 17:09:20 +0800</pubDate></item><item><title>【大咖来查房】瑞金·北京协和·中山肿瘤巅峰对话谈AL</title><link>https://mp.weixin.qq.com/s/ARejUyTBe8VyaQZELONrcw</link><description></description><content:encoded><![CDATA[【大咖来查房】瑞金·北京协和·中山肿瘤巅峰对话谈AL]]></content:encoded><pubDate>Tue, 11 May 2021 17:09:20 +0800</pubDate></item><item><title>口服阿扎胞苷和罗米地辛联合方案在PTCL中展现出较好疗效</title><link>https://mp.weixin.qq.com/s/eouFjSOX4k8lJd7X3nYgeQ</link><description></description><content:encoded><![CDATA[口服阿扎胞苷和罗米地辛联合方案在PTCL中展现出较好疗效]]></content:encoded><pubDate>Mon, 10 May 2021 17:25:14 +0800</pubDate></item><item><title>艾美赛珠单抗预防治疗A型血友病：HAVEN1-4研究长期随访结果</title><link>https://mp.weixin.qq.com/s/wOx7dx7IyqPsSH6oHmxK6Q</link><description></description><content:encoded><![CDATA[艾美赛珠单抗预防治疗A型血友病：HAVEN1-4研究长期随访结果]]></content:encoded><pubDate>Mon, 10 May 2021 17:25:14 +0800</pubDate></item><item><title>惊喜福利 | 麦粒、csco指南书籍、指南下载券任意选</title><link>https://mp.weixin.qq.com/s/yJtXuo9bcbM1F1aPVobf2A</link><description></description><content:encoded><![CDATA[惊喜福利 | 麦粒、csco指南书籍、指南下载券任意选]]></content:encoded><pubDate>Mon, 10 May 2021 17:25:14 +0800</pubDate></item><item><title>靶向BCMA的新CAR-T疗法，治疗多发性骨髓瘤值得期待</title><link>https://mp.weixin.qq.com/s/_FMXuOUi9WLnTLCVQkc1gg</link><description></description><content:encoded><![CDATA[靶向BCMA的新CAR-T疗法，治疗多发性骨髓瘤值得期待]]></content:encoded><pubDate>Mon, 10 May 2021 17:25:14 +0800</pubDate></item><item><title>强强联合丨四药方案D-KRd在NDMM患者中疗效显著</title><link>https://mp.weixin.qq.com/s/MwJwhae0kBhWJUFFvVynqQ</link><description></description><content:encoded><![CDATA[强强联合丨四药方案D-KRd在NDMM患者中疗效显著]]></content:encoded><pubDate>Sat, 08 May 2021 15:15:15 +0800</pubDate></item><item><title>漩涡里挣扎的中国医疗：让患者花钱的从来都不是医生</title><link>https://mp.weixin.qq.com/s/JKBRLOAsBcfhA2GL7oPojw</link><description></description><content:encoded><![CDATA[漩涡里挣扎的中国医疗：让患者花钱的从来都不是医生]]></content:encoded><pubDate>Sat, 08 May 2021 15:15:15 +0800</pubDate></item><item><title>罗氏重磅新药舒友立乐®在华斩获新适应症，助力更多A型血友病患者迈向“零出血”自由人生</title><link>https://mp.weixin.qq.com/s/gKKi9g2vYVllCT2DPxQKew</link><description></description><content:encoded><![CDATA[罗氏重磅新药舒友立乐®在华斩获新适应症，助力更多A型血友病患者迈向“零出血”自由人生]]></content:encoded><pubDate>Sat, 08 May 2021 16:35:03 +0800</pubDate></item><item><title>维布妥昔单抗联合DHAP治疗R/R cHL展现可观疗效</title><link>https://mp.weixin.qq.com/s/hvbF7QIWHZxYRMTRTv8rfw</link><description></description><content:encoded><![CDATA[维布妥昔单抗联合DHAP治疗R/R cHL展现可观疗效]]></content:encoded><pubDate>Sat, 08 May 2021 16:35:03 +0800</pubDate></item></channel></rss>